Welcome to the MDI website. Content and updating of information is ongoing on our website, therefore if you cannot find what you are looking for please contact us.
July 26th, 2022
Paxlovid™ is an oral medication used to treat COVID-19. It can be used to treat people who are at highest risk and should be taken in the first 5 days of illness. Due to the current high levels of COVID-19, the HSE has changed its guidelines meaning that more people can be considered for treatment with Paxlovid™ by their GP or hospital prescriber.
Paxlovid™ may not be suitable for all patients, but it can be considered for:
- Vaccinated people aged 75 or over
- Vaccinated people aged 65 or over who also have additional risks including obesity (BMI over 35), diabetes, high blood pressure, cardiovascular disease.
If you have COVID-19 symptoms and are at higher risk, talk to your GP or hospital team. You can read more about this on here.